Clinical Trials · NCT00193856
RADAR Trial - Randomised Androgen Deprivation and Radiotherapy
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Trans Tasman Radiation Oncology Group
- Enrollment
- 1,071
- Start date
- Oct 2003
- Locations
- 24 sites, Australia, New Zealand
- Primary endpoint
- Prostate cancer-specific mortality.